Guardant Health Stock Filter Stocks by Fundamentals
GH Stock | USD 16.67 0.28 1.71% |
Guardant Health fundamentals help investors to digest information that contributes to Guardant Health's financial success or failures. It also enables traders to predict the movement of Guardant Stock. The fundamental analysis module provides a way to measure Guardant Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guardant Health stock.
Guardant | Cash Flow from Operations |
Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
All Next | Launch Module |
Guardant Fundamentals
Return On Equity | -4.38 | ||||
Return On Asset | -0.18 | ||||
Profit Margin | (0.85) % | ||||
Operating Margin | (0.73) % | ||||
Current Valuation | 2.21 B | ||||
Shares Outstanding | 121.71 M | ||||
Shares Owned By Insiders | 4.10 % | ||||
Shares Owned By Institutions | 93.77 % | ||||
Number Of Shares Shorted | 7.64 M | ||||
Price To Earning | (12.01) X | ||||
Price To Book | 14.01 X | ||||
Price To Sales | 3.94 X | ||||
Revenue | 563.95 M | ||||
Gross Profit | 293.21 M | ||||
EBITDA | (519.63 M) | ||||
Net Income | (479.45 M) | ||||
Cash And Equivalents | 853.69 M | ||||
Cash Per Share | 8.35 X | ||||
Total Debt | 1.35 B | ||||
Debt To Equity | 4.32 % | ||||
Current Ratio | 6.18 X | ||||
Book Value Per Share | 1.30 X | ||||
Cash Flow From Operations | (324.98 M) | ||||
Short Ratio | 4.10 X | ||||
Earnings Per Share | (4.28) X | ||||
Price To Earnings To Growth | (0.66) X | ||||
Target Price | 39.06 | ||||
Number Of Employees | 1.77 K | ||||
Beta | 0.9 | ||||
Market Capitalization | 2.03 B | ||||
Total Asset | 1.79 B | ||||
Retained Earnings | (2.14 B) | ||||
Working Capital | 1.14 B | ||||
Current Asset | 219.68 M | ||||
Current Liabilities | 24.24 M | ||||
Net Asset | 1.79 B |
About Guardant Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guardant Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardant Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardant Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Guardant Health Piotroski F Score and Guardant Health Altman Z Score analysis. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Stocks Directory Find actively traded stocks across global markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.036 | Quarterly Revenue Growth 0.222 | Return On Assets (0.18) | Return On Equity (4.38) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.